Dementia News and Research

Latest Dementia News and Research

People with schizophrenia are 2.5 times more likely to develop dementia

People with psychotic disorders such as schizophrenia are 2.5 times more likely than those without a psychotic disorder to eventually develop dementia, according to a review of evidence led by UCL researchers.

6 Oct 2022

The neuroprotective potential of Cannabis sativa L. against Alzheimer's disease

A recent study assesses the neuroprotective potential of the active constituents of cannabis in treating dementia and Alzheimer's disease.

6 Oct 2022

Omega-3 levels could play a role in improving cognitive resilience in middle-aged people

An exploratory study suggests that people who eat more foods with omega-3 fatty acids in midlife may have better thinking skills and even better brain structure than people who eat few foods with the fatty acids.

5 Oct 2022

Consuming more omega-3s associated with better brain health and cognition in middle age

Eating cold-water fish and other sources of omega-3 fatty acids may preserve brain health and enhance cognition in middle age, new evidence indicates.

5 Oct 2022

Decline in specific protein levels linked to Alzheimer’s disease, not buildup of amyloid plaques

New research from the University of Cincinnati bolsters a hypothesis that Alzheimer's disease is caused by a decline in levels of a specific protein, contrary to a prevailing theory that has been recently called into question.

5 Oct 2022

Viagra and Cialis may not be suitable candidates for treating dementia, NIH DREAM study shows

Results from the National Institutes of Health's Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study show that sildenafil (Viagra) and tadalafil (Cialis) may not be suitable candidates for treating dementia.

4 Oct 2022

Eligibility criteria lack clarity, justification for excluding people with disabilities from clinical trials

Despite constituting the largest minority group in the U.S. and expressing interest in participating in clinical trials, people with disabilities remain excluded.

3 Oct 2022

Study: Fewer Black, Hispanic and Asian patients qualify for treatments that slow Alzheimer's progression

The development of anti-amyloid monoclonal antibodies that may slow the progression of Alzheimer's disease by breaking down amyloid plaques, a hallmark of the disease, has brought fresh hope to aging populations and the doctors who treat them.

3 Oct 2022

New algorithm may help predict the risk of Alzheimer's dementia

When people participate in studies of aging, they often want to know what their individual risks of developing dementia from Alzheimer's disease are. Washington University researchers have developed an algorithm that can help provide them with information about what their risks may be.

30 Sep 2022

Researchers compare end-of-life care in persons with and without dementia

Researchers have known that race and ethnicity play a role in the intensity of medical care at the end of life, but the difference is more pronounced among individuals with dementia, the researchers found.

30 Sep 2022

Alzheimer’s researchers highlight the need for inclusive clinical trials

Enrolling representative populations in clinical trials for Alzheimer's disease is critical for finding treatments that will be safe and effective for all patients. African Americans and Latinos are disproportionately affected by this disease yet are substantially underrepresented in trials of promising therapies. For example, an analysis of data from more than 100 clinical trials testing new treatments for Alzheimer's disease found that only 12% of participants were of any non-White race or Hispanic ethnicity.

30 Sep 2022

Researchers find link between metabolism and dementia-related brain measures

Every three seconds, someone in the world is diagnosed with dementia. And while there is no known cure, changes in the brain can occur years before a dementia diagnosis.

30 Sep 2022

Increased risk for all-cause dementia in people who abstain from alcohol

Alcohol abstinence increases the risk for dementia in later life, according to a recent study published in the journal Addiction. Furthermore, neuroimaging records suggest that even low alcohol consumption levels could harm brain health, as does the dose-response relationship between alcohol use and systemic diseases, such as metabolic diseases and certain cancers.

30 Sep 2022

Artificial intelligence used to predict hospitalization outcomes of geriatric patients with dementia

By using artificial intelligence, Houston Methodist researchers are able to predict hospitalization outcomes of geriatric patients with dementia on the first or second day of hospital admission.

29 Sep 2022

Study aims to understand how SARS-CoV-2 affects the brain long-term

Researchers formulate a method to identify the molecular and systemic factors linking COVID-19 to short- and long-term neurologic illness.

28 Sep 2022

Treatment for neurological diseases often no longer effective enough in the later stages

Neurological diseases often begin with an inflammatory process and the degradation of the so-called myelin layer, which surrounds the nerve fibers (axons) like a protective insulating layer.

28 Sep 2022

High blood pressure causes faster cognitive decline, new study finds

People with high blood pressure levels face a faster erosion of their ability to think, make decisions and remember information than those with normal blood pressure levels, a new study finds.

28 Sep 2022

Cycles of fasting-mimicking diet appear to reduce signs of Alzheimer’s in mice

Cycles of a diet that mimics fasting appear to reduce signs of Alzheimer's in mice genetically engineered to develop the illness, according to a new USC Leonard Davis School of Gerontology-led study.

27 Sep 2022

Some pre-existing conditions matter a lot more when assessing COVID-19 outcomes

A new paper in Biology Methods & Protocols, published by Oxford University Press, indicates that some pre-existing conditions - including degenerative neurological diseases, dementia, and severe disabilities - matter a lot more than once thought when assessing who is at risk for death due to COVID-19.

27 Sep 2022

The potential of NMR-based blood profiling as a single-domain assay to simultaneously predict multidisease onset

Researchers explored the potential of a nuclear magnetic resonance spectroscopy-based metabolomic platform to estimate the risks for the onset of several medical conditions.

27 Sep 2022

Dementia News and Research

Latest Dementia News and Research

People with schizophrenia are 2.5 times more likely to develop dementia

The neuroprotective potential of Cannabis sativa L. against Alzheimer's disease

Omega-3 levels could play a role in improving cognitive resilience in middle-aged people

Consuming more omega-3s associated with better brain health and cognition in middle age

Decline in specific protein levels linked to Alzheimer’s disease, not buildup of amyloid plaques

Viagra and Cialis may not be suitable candidates for treating dementia, NIH DREAM study shows

Eligibility criteria lack clarity, justification for excluding people with disabilities from clinical trials

Study: Fewer Black, Hispanic and Asian patients qualify for treatments that slow Alzheimer's progression

New algorithm may help predict the risk of Alzheimer's dementia

Researchers compare end-of-life care in persons with and without dementia

Alzheimer’s researchers highlight the need for inclusive clinical trials

Researchers find link between metabolism and dementia-related brain measures

Increased risk for all-cause dementia in people who abstain from alcohol

Artificial intelligence used to predict hospitalization outcomes of geriatric patients with dementia

Study aims to understand how SARS-CoV-2 affects the brain long-term

Treatment for neurological diseases often no longer effective enough in the later stages

High blood pressure causes faster cognitive decline, new study finds

Cycles of fasting-mimicking diet appear to reduce signs of Alzheimer’s in mice

Some pre-existing conditions matter a lot more when assessing COVID-19 outcomes

The potential of NMR-based blood profiling as a single-domain assay to simultaneously predict multidisease onset

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Dementia News and Research

Latest Dementia News and Research

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in